| Name | Title | Contact Details |
|---|
Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.
Salient Surgical Technologies, Inc. is a Portsmouth, NH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The CVMC Care Team is over 600 members strong, with nearly 40 active medical staff professionals and approximately 100 courtesy, consulting and Emergency Department staff members. 19 areas of medical specialization are currently represented through the state-of-the-art 248-bed facility, with plans for added services on the horizon. As an independent, non-profit hospital, CVMC is solely focused on delivering the highest quality of health care to Sylacauga and its surrounding communities.
Detroit Institute for Children is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Care n' Care Health Plan is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.